Furthermore, the measurement of cerebrospinal fluid Lcn2 levels might be able to diagnose brain damage due to Alzheimer’s disease, traumatic brain injury and chronic stress [73,74]. This evidence concerns the gene LCN2 and early-onset autosomal dominant Alzheimer disease.